Login / Signup

Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish.

Boon Chong GohSimon LarssonLinh Chi DamYan Han Sharon LingWei Lin Patrina ChuaR AbiramiSamsher SinghJun Long Ernest OngJeanette W P TeoPeiying HoPhilip W InghamKevin PethePeter C Dedon
Published in: JAC-antimicrobial resistance (2023)
The data indicate that the rifaximin/clarithromycin combination is promising to effectively treat pulmonary NTM infections.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • irritable bowel syndrome
  • pulmonary hypertension
  • mycobacterium tuberculosis
  • electronic health record
  • big data